Open Access Open Access  Restricted Access Subscription Access

Antimicrobial Sulpha Drugs

S. Sreeremya

Abstract


Sulphonamides are chemotherapeutic agents. Sulphonamides can be derived from biological and synthetic sources. It has great prominence in pharmacology. This paper deals with the structure, chracteristics, antimicrobialactivities of sulphonamide and its derivatives.


Full Text:

PDF

References


E. Kurzer, S. A. Kaplan, Cost effectiveness model comparing trimethoprim sulfamethoxazole and ciprofloxacin for the treatment of chronic bacterial prostatitis, European Urology, 42 (2002) 163-166.

R. W. Snyder, D. B. Glasser, Antibiotic Therapy for Ocular Infection, Western Journal of Medicine, 161 (1994) 579- 584.

M. Soheilian, M. Sadoughi, M. Ghajarnia, M. H. Dehghan, S. Yazdani, H. Behboudi, A. Anisian, G. A. Peyman, Prospective randomized trial of trimethoprim/ sulfamethoxazole versus pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis, Ophthalmology, 112(11) (2005) 1876-1882.

M. A. Gerber, R. S. Baltimore, C. B. Eaton, M. Gewitz, K. A. Taubert, Prevention of rheumatic fever and diagnosis and treatment of acute streptococcal pharyngitis, Circulation,119 (2009) 1541-1551.

D. M. Livermore, S. Mushtaq, M. Wamer, N. Woodford, Comparative in vitro activity of sulfametrole/trimethoprim and sulfamethoxazole/trimethoprim and other agents against multiresistant Gram-negative bacteria, Journal of Antimicrobial Chemotherapy, 69 (2014) 1050-1056.

T. B. Vree, E. Schoondermark-van de Ven, C. P. W. G. M. Vervey-van Wissen, A. M. Baars, A. Swolfs, P. M. van Galen, H. Amatdjais-Groenen, Isolation, identification and determination of sulfadiazine and its hydroxy metabolites and conjugates from man and Rhesus monkey by high-performance liquid chromatography, Journal of Chromatography B, 670 (1995) 111-123.

Z. Berkani, Y. Kitouni, A. Lakehal, D. Roula, Trimethoprim/ sulfamethoxazole and azithromycin combination in the treatment of presumed ocular toxoplasmosis, Investigative Ophthalmology & Visual Science, 56 (2015) 1894.

Y. Sakiyama, N. Kanda, Y. Higuchi, M. Yoshimura, H. Wakaguri, Y. Takata, O. Watanabe, J. Yuan, Y. Tashiro, R. Saigo, S. Nozuma, A. Yoshimura, S. Arishima, K.Ikeda, K. Shinohara, H. Arata, K. Michizono, K. Higashi, A. Hashiguchi, Y. Okamoto, R. Hirano, T. Shiraishi, E. Matsuura, R. Okubo, I. Higuchi, M. Goto, H. Hirano, A. Sano, T. Iwasaki, F. Matsuda, S. Izumo, H. Takashima, New type of encephalomyelitis responsive to trimethoprim/ sulfamethoxazole treatment in Japan, Neurology: Neuroimmunology & Neuroinflammation, 2(5) (2015)e143.

A. Yazici, P. C. Ozdal, I. Taskintuna, S. Kavuncu, G. Koklu, Trimethoprim/sulfamethoxazole and azithromycin combination therapy for ocular toxoplasmosis, Ocular Immunology and Inflammation, 17(4) (2009) 289-291.

P. Franks, J. A. Gleiner, The treatment of acute bronchitis with trimethoprim and sulfamethoxazole, The Journal of Family Practice, 19 (1984) 185-190.

J. M. McCarthy, G. Richard, W. Huck, R. M. Tucker, R. L. Tosiello, M. Shan, A. Heyd, R. M. Echols, A randomized trial of short-course ciprofloxacin, ofloxacin, or trimethoprim/sulfamethoxazole for the treatment of acute urinary tract infection in women. Ciprofloxacin urine tract infection group, The American Journal of Medicine, 106 (1999) 292-299.

Luiz Everson da silva et al. In Vitro Antiprotozoal Evaluation of Zinc and Copper Complexes Basedon Sulfonamides Containing 8-Aminoquinoline Ligands. Letters in drug design and discovery, 2010,7, 679-685.

D silva et al., Synthesis and in vitro evaluation of leishmanicidal and trypanocidal activities of N-quinolin-8-yl aryl-sulfonamides. Bioorg. Med. Chem.,2007,15, 7553-7560.

Sapna R., Ajeet, Arvind K., “Designing of Sulfanilamide/Sulfacetamide Derivatives as Human Topoisomerase II Inhibitor: A Docking Approach”. American Journal of Pharmacological Sciences, 2(2), 42-46, 2014.

Reiss, WG; Oles, KS (May 1996). "Acetazolamide in the treatment of seizures.” The Annals of Pharmacotherapy. 30 (5): 514–9.

.Rose, BD (Feb 1991). "Diuretics.". Kidney International. 39 (2): 336–52.

Masereel B., Rolin S., Abbate F., Scozzafava A., Supuran C. T.,2011. “Carbonic anhydrase inhibitors: anticonvulsant sulfonamides incorporating valproyl and other lipophilic moieties”. J. Med. Chem., 45(2), 312-320, 2002.

M.S.A. El-Gaby, ,A.M. Gaber, A.A. Atalla, K.A. Abd Al-Wahab.2015. “Novel synthesis and antifungal activity of pyrrole and pyrrolo[2,3-d]pyrimidine derivatives containing sulfonamido moieties” Farmaco. 57(8): 613-617.

Bekdemir Y, Kütük H, Özkanca R, Mara° FZ, Darcan C, Çelik S, Isik K. 2010.Substituent effects on antimicrobial activities of some sulfonamides. The 15th International symposium on quantitive structure-activity relationships&molecular modeling.

Mengelers MJ, Hougee PE, Jansson LH, Van Miert AS. Structure-activity relationship between antibacterial activities and physicochemical properties of sulfonamides. J Vet Pharmacol Therap. 1997;20:276–283.


Refbacks

  • There are currently no refbacks.